CKD-330 Phase 3 Trial in Amlodipine Non-responder
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT02586311
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 160 participants
- Registry
-
NCT02586311
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02586311. Randomized; double masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2016-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CKD-330 Phase 3 Trial in Amlodipine Non-responder
- Condition
- Hypertension
- Intervention (Drug)
- CKD-330 16/5mg
- Intervention (Drug)
- Amlodipine 5mg Placebo
- Intervention (Drug)
- CKD-330 16/5mg Placebo
- Intervention (Drug)
- Amlodipine 5mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct02586311- Content hash
efabd18a3d620aa154e161acecc2475ee862472782955010d705a1435255edc3